Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Title:ACKNOWLEDGEMENTS TO CONTRIBUTORS (2014-2015)
Volume: 9 Issue: 2
Export Options
About this article
Cite this article as:
ACKNOWLEDGEMENTS TO CONTRIBUTORS (2014-2015), Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2015; 9 (2) . https://dx.doi.org/10.2174/187221480902151221161502
DOI https://dx.doi.org/10.2174/187221480902151221161502 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
17
Related Articles
-
Pathophysiology of NASH: Perspectives for a Targeted Treatment
Current Pharmaceutical Design Recent Patents on Cell-based Approaches to Collagen Enrichment and Repair
Recent Patents on Regenerative Medicine Carnosine and Diabetic Nephropathy
Current Medicinal Chemistry The Identification and Analysis of MicroRNAs Combined Biomarkers for Hepatocellular Carcinoma Diagnosis
Medicinal Chemistry Profile of Secondary Bacterial Respiratory Infections in H1N1 Patients Admitted in a Tertiary Care Centre – A Four-year Retrospective Study
Infectious Disorders - Drug Targets Characterisation of Mitochondrial DNA Deletions by Long-PCR in Central Nervous System Regions of Young, Middle- and Old-aged Rats
Current Aging Science Competitive Fluorescence Polarization Assays for the Detection of Phosphoinositide Kinase and Phosphatase Activity
Combinatorial Chemistry & High Throughput Screening Various Non-Injectable Delivery Systems for the Treatment of Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting “Undruggable” Proteins: Design of Synthetic Cyclopeptides
Current Medicinal Chemistry Animal Models of Addiction: Fat and Sugar
Current Pharmaceutical Design Polymeric Nanomicelles of Soluplus® as a Strategy for Enhancing the Solubility, Bioavailability and Efficacy of Poorly Soluble Active Compounds
Current Nanomedicine Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality
Current Drug Targets Rasburicase-Induced Methemoglobinemia in a Patient with Glucose-6- Phosphate Dehydrogenase Deficiency
Current Drug Safety Cancer Cachexia: Molecular Targets and Pathways for Diagnosis and Drug Intervention
Endocrine, Metabolic & Immune Disorders - Drug Targets Roles of Type 10 17beta-Hydroxysteroid Dehydrogenase in Intracrinology and Metabolism of Isoleucine and Fatty Acids
Endocrine, Metabolic & Immune Disorders - Drug Targets Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women
Recent Patents on Anti-Cancer Drug Discovery Editorial (Thematic Issue : Recent Advances in Cancer Research: Targets and New Ligands)
Current Pharmaceutical Design Proteinase Inhibitors: A Promising Drug Class for Treating Leishmaniasis
Current Drug Targets Interval Exercise Therapy for Type 2 Diabetes
Current Diabetes Reviews Nonmuscle Myosin Heavy Chain and Histone H3 are Intracellular Binding Partners of Lithospermic Acid B and Mediate its Antiproliferative Effect on VSMCs
Current Medicinal Chemistry